Low-energy fractures complications are a major public health issue that make osteoporosis even worse. In sub-Saharan Africa, the prevalence of osteoporosis varies from 18.2% to 65.8%. There was no change in bone mineral density between HIV-infected and non-HIV-infected women in Sub-Saharan Africa, where HIV is widespread. Other investigations that demonstrated that HIV-infected people had poor BMD both before and after starting anti-retroviral treatment did not consistently show a low BMD finding. Inflammation-mediated bone remodelling has been associated with low BMD in HIV-infected patients. Antiretroviral Therapy has been demonstrated to exacerbate bone loss in addition to the pre-existing intrinsic risk of developing osteoporosis.

Question: Is there loss of bone in HIV-infected patients before initiating ART?

The patients who were HIV-positive and enrolled in the ADVANCE research were retrospectively reviewed on a desk. All of the 1053 individuals in the ADVANCE research had a DXA scan performed to evaluate BMD as part of the initial screening and recruitment approach. The ADVANCE research enrolled HIV-positive people and randomly assigned them to three ART arms.

A total of 400 patients were reviewed. Of these 400 records reviewed, 62.3% were female. 80% of the participants were younger than 40 years old, and 3% were older than 50 years. 82% were virally suppressed with less than 50 viral copies. The prevalence of osteopenia was 25.5% and osteoporosis was 2.8%, observed in predominantly African female participants aged between 30 and 39 years.

The findings of this study confirm that there is pre-existing bone loss among HIV-infected ART naïve individuals. Approximately 28.3% in our study had clinically confirmed evidence of bone loss and of these, 2.8% of the entire cohort had osteoporosis. Bone loss was most prevalent in black females who are virologically suppressed.

Osteoporosis is common and the health and financial cost of fragility fractures is considerable. The burden of cardiovascular disease has been reduced dramatically by identifying and targeting those most at risk. A similar approach is potentially possible in the context of fragility fractures. The World Health Organization created and endorsed the use of FRAX, a fracture risk assessment tool, which uses selected risk factors to calculate a quantitative, patient-specific, ten-year risk of sustaining a fragility fracture. Treatment can thus be based on this as well as on measured bone mineral density. It may also be used to determine at-risk individuals, who should undergo bone densitometry. FRAX has been incorporated into the national osteoporosis guidelines of countries in the Americas, Europe, the Far East and Australasia. The United Kingdom National Institute for Health and Clinical Excellence also advocates its use in their guidance on the assessment of the risk of fragility fracture, and it may become an important tool to combat the health challenges posed by fragility fractures

Aims

This study explored the shared genetic traits and molecular interactions between postmenopausal osteoporosis (POMP) and sarcopenia, both of which substantially degrade elderly health and quality of life. We hypothesized that these motor system diseases overlap in pathophysiology and regulatory mechanisms.

Orthopaedic surgeons frequently assess fragility fractures (FF), however osteoporosis (OP) is often managed by primary care physicians (PCP). Up to 48% of FF patients have had a previous fracture (Kanis et al., 2004). Discontinuity between fracture care and OP management is a missed opportunity to reduce repeat fractures. This studied aimed to evaluate current OP management in FF patients presenting to cast clinic.

A single centre, prospective observational study where seven traumatologists screened for FF in cast clinic. FF was defined as a hip, distal radius (DR), proximal humerus (PH), or ankle fracture due to a ground level fall. Patients completed a self-administered questionnaire for demographics, fracture type and treatment, medical and fracture history, and previous OP care. The primary outcome was number of FF patients who received OP investigation and/or treatment. Secondary outcomes included Fracture Risk Assessment Tool (FRAX), repeat fracture rate, and anti-resorptive related fractures. Descriptive statistics were used for analysis.

Between November 17, 2014 and October 13, 2015, a total of 1,677 patients attended cast clinic for an initial assessment. FF were identified in 120 patients (7.2%). The FF cohort had a mean age of 65.3 (± 14.3) years, mean BMI of 26.1 (± 5.3), and was comprised of 83.3% females. Fracture distribution was 69 (57.5%) DR, 23 (19%) ankle, 20 (16.5%) PH, and seven (5.8%) hip fractures, with 24 of the FF (19.8%) treated operatively. Thirteen (10.8%) were current smokers and 40 (33.3%) formerly smoked. A history of steroid use was present in 13 patients (10.8%). Ninety (n = 117; 76.9%) of patients ambulated independently. Twenty-two patients (18.3%) reported prior diagnosis of OP, most often by a PCP (n = 19; 73.7%) over 5 years previously. Calcium (n = 59; 49.2%) and Vitamin D (n = 70; 58.3%) were common and 26 patients (21.5%) had a prior anti-resorptive therapy, with Alendronate (n = 9) being most common. One patient had an anti-resorptive-related fracture. Raloxifene was used in ten patients. Forty-seven patients (39.2%) had a prior fracture at a mean age of 61.3 (± 11.9) years, with DR and PH fractures being most common. Eleven patients had two or more prior fractures. A family history of OP was found in 34 patients (28.1%). Mean FRAX score was 20.8% (± 10.8%) 10-year major fracture risk and 5.9% (± 6.6%) 10-year hip fracture risk (n = 30 bone densiometry within one-year). Of the 26 patients with a Moderate (10–20%) or High (> 20%) 10-year major fracture risk, only eight (30.8%) reported a diagnosis of OP and only three (11.5%) had seen an OP specialist.

Cast clinics provide an opportunity for OP screening, initiation of treatment, and patient education. This cohort demonstrated a high rate of repeat fractures and poor patient reporting of prior OP diagnosis. This study likely underestimated FF and calls for resource allocation for quantifying true burden of disease and outpatient fracture liaison service.

An osteoporosis screening service for patients presenting to the fracture clinic in Derriford Hospital Plymouth was established in February 2009. We report on the findings of the first year of patients referred for dual energy X-ray absorptiometry (DEXA) screening.

Patients between 50 and 75 years of age, who sustained a fracture as a result of a fall from standing height or less, who had not previously had a DEXA scan within the last two years, were referred. Patients outside these age limits with other risk factors for osteoporosis were scanned at the discretion of the fracture clinic consultant. Of those patients who were referred, 96% subsequently attended for a scan timed to coincide with their scheduled fracture clinic follow-up appointment.

402 patients were scanned in total, of which 351 were female and 51 were male. The mean patient age was 65. The results for women were as follows: 21% normal, 45% osteopenic, 34% osteoporotic. The results for men were: 19% normal, 43% osteopenic, 38% osteoporotic. The scan results were forwarded to the patient's general practitioner for action as deemed necessary.

These findings support the establishment of this screening service for both men and women.

Purpose

To describe the implication of Family Physicians (FPs) in the management of osteoporosis revealed by a fragility fracture.

Internal fixation for supracondylar fracture of the femur after total knee arthroplasty (TKA) is technically difficult and troublesome because the distal bony fragment is often osteoporotic and too small to fix by screws or K-wires. In addition, the femoral component interferes with the screws or K-wires to be inserted from distal direction for fixation of the fracture.

In Alberta there are over 2,700 hip fractures per year costing the health system over $24 million in acute care costs alone. 50% of hip fracture patients have had a prior fragility fracture as a result of underlying osteoporosis (OP) that has never been assessed or appropriately treated. The Fracture Liaison Service (FLS) in Alberta aims to improve appropriate osteoporosis care, highlight and address gaps within seniors care through OP management, and provide a geriatric syndrome triage service.

The FLS has developed a linkage with the Emergency Department (ED) geriatric team whereby hip fracture patients are identified in ED using a screening tool for geriatric syndromes prior to their surgery, allowing the FLS to follow through on comorbidities likely contributing to falls. An inpatient orthopaedic unit with a dedicated Registered Nurse (RN) and a Care of the Elderly Physician see and assess hip fracture patients after surgery for appropriate osteoporosis management and treatment. Screening tools have been developed to quickly detect underlying dementia and to quantify frailty to determine life expectancy and appropriate osteoporosis therapy. Patients are also referred to Geriatric Assessment Units and fall prevention programs. Patients are then contacted in the community at 3, 6,9,12 months by the FLS RN to follow up on osteoporosis therapy, and arrange other needed tests (i.e. bone mineral density, vitamin D) as needed. Information is sent to their family physician with all results. Prior to the patient's discharge from the FLS at one year, a final hand-over letter from the program will be provided outlining the plan of care for the patient.

The FLS launched in June 2015 at the Misericordia hospital in Edmonton, Alberta (with plans to expand provincially). Currently 3 out of 4 hip fracture patients per week are being identified in the ED. Ninety-eight hip fracture patients have been identified post-surgery, with 71 patients eligible for enrollment in the program (five deceased patients). Sixty-six (50%) of those enrolled were discharged on osteoporosis medication compared to 8% prior to the program initiation. Seventeen (26%) of those were new medication starts. Of those not started, 7(11%) was patient choice. 11(31%) will be reassessed at 3 months for appropriate therapy. Nineteen (27%) of patients were referred to other inpatient or outpatient programs (i.e. falls, memory). Three month follow up calls have begun with patients for further data collection and a full 1 year qualitative and quantitative evaluation will be done.

The implementation of an FLS with dedicated personnel to proactively manage and treat patients with appropriate investigations and interventions can close the care gap that exists in OP care. It also addresses gaps in senior care and provides appropriate referral to community geriatric programs, to improve quality of life and prevent future fractures.

Osteoporosis accounts for a leading cause of degenerative skeletal disease in the elderly. Osteoblast dysfunction is a prominent feature of age-induced bone loss. While microRNAs regulate osteogenic cell behavior and bone mineral acquisition, however, their function to osteoblast senescence during age-mediated osteoporosis remains elusive. This study aims to utilize osteoblast-specific microRNA-29a (miR-29a) transgenic mice to characterize its role in bone cell aging and bone mass. Young (3 months old) and aged (9 months old) transgenic mice overexpressing miR-29a (miR-29aTg) driven by osteocalcin promoter and wild-type (WT) mice were bred for study. Bone mineral density, trabecular morphometry, and biomechanical properties were quantified using μCT imaging, material testing system and histomorphometry. Aged osteoblasts and senescence markers were probed using immunofluorescence, flow cytometry for apoptotic maker annexin V, and RT-PCR. Significantly decreased bone mineral density, sparse trabecular morphometry (trabecular volume, thickness, and number), and poor biomechanical properties (maximum force and breaking force) along with low miR-29a expression occurred in aged WT mice. Aging significantly upregulated the expression of senescence markers p16INK4a, p21Waf/Cip1, and p53 in osteoporotic bone in WT mice. Of note, the severity of bone mass and biomechanical strength loss, as well as bone cell senescence, was remarkably compromised in aged miR-29aTg mice. In vitro, knocking down miR-29a accelerated senescent (β-galactosidase activity and senescence markers) and apoptotic reactions (capsas3 activation and TUNEL staining), but reduced mineralized matrix accumulation in osteoblasts. Forced miR-29a expression attenuated inflammatory cytokine-induced aging process and retained osteogenic differentiation capacity. Mechanistically, miR-29a dragged osteoblast senescence through targeting 3′-untranslated region of anti-aging regulator FoxO3 to upregulate that of expression as evident from luciferase activity assessment. Low miR-29a signaling speeds up aging-induced osteoblast dysfunction and osteoporosis development. Gain of miR-29a function interrupts osteoblast senescence and shields bone tissue from age-induced osteoporosis. The robust analysis sheds light to the protective actions of miR-29a to skeletal metabolism and conveys a perspective of miR-29a signaling enhancement beneficial for aged skeletons

Fragility fractures associated with osteoporosis (OP) reduce quality of life, increase risk for subsequent fractures, and are a major economic burden. In 2010, Osteoporosis Canada produced clinical practice guidelines on the management of OP patients at risk for fractures (Papaioannou et al. CMAJ 2010). We describe the real-world incidence of primary and subsequent fragility fractures in elderly Canadians in Ontario, Canada in a timespan (2011–2017) following guideline introduction. This retrospective observational study used de-identified health services administrative data generated from the publicly funded healthcare system in Ontario, Canada from the Institute for Clinical Evaluative Sciences. The study population included individuals ≥66 years of age who were hospitalized with a primary (i.e. index) fragility fracture (identified using ICD-10 codes from hospital admissions, emergency and ambulatory care) occurring between January 1, 2011 and March 31, 2015. All relevant anatomical sites for fragility fractures were examined, including (but not limited to): hip, vertebral, humerus, wrist, radius and ulna, pelvis, and femur. OP treatment in the year prior to fracture and subsequent fracture information were collected until March 31, 2017. Patients with previous fragility fractures over five years prior to the index fracture, and those fractures associated with trauma codes, were excluded. 115,776 patients with an index fracture were included in the analysis. Mean (standard deviation) age at index fracture was 80.4 (8.3) years. In the year prior to index fracture, 32,772 (28.3%) patients received OP treatment. The incidence of index fractures per 1,000 persons (95% confidence interval) from 2011–2015 ranged from 15.16 (14.98–15.35) to 16.32 (16.14–16.51). Of all examined index fracture types, hip fractures occurred in the greatest proportion (27.3%) of patients (Table). The proportion of patients incurring a second fracture of any type ranged from 13.4% (tibia, fibula, knee, or foot index fracture) to 23% (vertebral index fracture). Hip fractures were the most common subsequent fracture type and the proportion of subsequent hip fractures was highest in patients with an index hip fracture (Table). The median (interquartile range [IQR]) time to second fracture ranged from 436 (69–939) days (radius and ulna index fracture) to 640 (297–1,023) days (tibia, fibula, knee, or foot index fracture). The median (IQR) time from second to third fracture ranged from 237 (75–535) days (pelvis index fracture) to 384 (113–608) days (femur index fracture). This real-world study found that elderly patients in Ontario, Canada incurring a primary fragility fracture from 2011–2015 were at risk for future fractures occurring over shorter periods of time with each subsequent fracture. These observations are consistent with previous reports of imminent fracture risk and the fragility fracture cascade in OP patients (Balasubramanian et al. ASBMR 2016, Toth et al. WCO-IOF-ESCEO 2018). Overall, these data suggest that in elderly patients with an index fragility fracture at any site (with the exception of the radius or ulna), the most likely subsequent fracture will occur at the hip in less than 2 years

Recent clinical data suggest improvement in the fixation of tibia trays for total knee arthroplasty when the trays are additive manufactured with highly porous bone ingrowth structures. Currently, press-fit TKA is less common than press-fit THA. This is partly because the loads on the relatively flat, porous, bony apposition area of a tibial tray are more demanding than those same porous materials surrounding a hip stem. Even the most advanced additive manufactured (AM) highly porous structures have bone ingrowth limitations clinically as aseptic loosening still remains more common in press-fit TKA vs. THA implants. Osseointegration and antibacterial properties have been shown in vitro and in vivo to improve when implants have modified surfaces that have biomimetic nanostructures designed to mimic and interact with biological structures on the nano-scale. Pre-clinical evaluations show that TiO. 2. nanotubes (TNT), produced by anodization, on Ti6Al4V surfaces positively enhance the rate at which osseointegration occurs and TNT nano-texturization enhances the antibacterial properties of the implant surface. 2. In this in vivo sheep study, identical Direct Metal laser Sintered (DMLS) highly porous Ti6Al4V specimens with and without TNT surface treatment are compared to sintered bead specimens with plasma sprayed hydroxyapatite-coated surface treatment. Identical DMLS specimens made from CoCrMo were also implanted in sheep tibia bi-cortically (3 per tibia) and in the cancellous bone of the distal femur and proximal tibia (1 per site). Animals were injected with fluorochrome labels at weeks 1, 2 and 3 after surgery to assess the rate of bone integration. The cortical specimens were mechanically tested and processed for PMMA histology and histomorphometry after 4 or 12 weeks. The cancellous samples were also processed for PMMA histology and histomorphometry. The three types of bone labels were visualized under UV light to examine the rate of new bony integration. At 4 weeks, a 42% increase in average pull-out shear strength between nanotube treated specimens and non-nanotube treated specimens was shown. A 21% increase in average pull-out shear strength between nanotube treated specimens and hydroxyapatite-coated specimens was shown. At 12 weeks, all specimens had statistically similar pull-out values. Bone labels demonstrated new bone formation into the porous domains on the materials as early as 2 weeks. A separate in vivo study on 8 rabbits infected with methicillin-resistant Staphylococcus aureus showed bacterial colonization reduction on the surface of the implants treated with TNT. In vitro and in vivo evidence suggests that nanoscale surfaces have an antibacterial effect due to surface energy changes that reduce the ability of bacteria to adhere. These in vivo studies show that TNT on highly porous AM specimens made from Ti6Al4V enhances new bone integration and also reduce microbial attachment

Aims

Disorders of bone integrity carry a high global disease burden, frequently requiring intervention, but there is a paucity of methods capable of noninvasive real-time assessment. Here we show that miniaturized handheld near-infrared spectroscopy (NIRS) scans, operated via a smartphone, can assess structural human bone properties in under three seconds.

Surface coatings have been introduced to total joint orthopaedics over the past decades to enhance osseointegration between metal implants and bone. However, complications such as aseptic loosening and infection persist. Inadequate osseointegration remains a complication associated with implants that rely on osseointegration for proper function. This is particularly challenging with implants having relatively flat and small surface areas that have high shear loading, such as noncemented uni and total condylar knee tibial trays. Faster osseointegration can enhance recovery as a result of improved load distribution and a more stable bone-implant interface. Traditionally noncemented porous bone ingrowth coatings on knee, hip and shoulder implants are typically texturised by thermal plasma spray coating, sintered metal bead coatings, or 3-D additive manufactured structures that provide porous surface features having the rough texture with pore sizes on the order of 150 to 300 micrometers. These surfaces are often further chemically enhanced with hydroxyapatite (HA) deposition. This provides macro-mechanical (millimeter scale) and micro-mechanical (micrometer scale) bone remodeling into the implant surface. However, at the nanoscale and cellular level, these surfaces appear relatively smooth. More recent studies are showing the importance of controlling the macro, micro, and the nano (nanometer scale) surface topographies to enhance cell interaction. In vitro and in vivo research shows surfaces with nanoscale features in the metal substrate result in enhanced osseointegration, greater bone-implant contact area and pullout force, and potentially bactericidal. One surface modification treatment technique of particular promise is nano-texturing via electrochemical anodization to bio-mimicking TiO2 nanotube arrays that are superimposed onto existing porous surface microstructures to further enhance the already known bone ingrowth properties of these porous structures by superimposing onto the existing microstructure arrays of nanotubes approximately 100 nanometers in outside diameter and 300–500 nanometers in height. In an ovine model, 3-D printed Direct Metal Laser Deposition (DMLS) additive manufactured porous Ti-6Al-4V implant with and without TiO2 nanotube array nano-texturing were compared to similar sized implants with commercially available sintered beads with HA coating and additive manufactured cobalt chrome implants. The average bond strength was significantly higher (42%) when the implants were nano-texturised and similarly stronger (53%) compared to HA coated sintered bead implants. Histology confirms over 420% more direct bonded growth of new bone from 0.5mm to 1.0mm deep into the porosity on the implants when the same implants are nano-texturised. Nano-texturing also changes the surface of the implant to repel methicillin-resistant staphylococcus aureus (MRSA) in an in vivo rabbit model limiting biofilm formation on the porous surface compared with non-treated porous surfaces. Since nano-texturizing only modifies the nano-morphology of the surface and does not add antibiotics or other materials to the implant, these animal studies shows great promise that nano-texturizing the TiO2 coating may not only enhance osseointegration, but also repels bacteria from porous implant surfaces. As such, we believe nano-texturing of porous implants will be the next advancement in surface coating technology

Titanium (Ti) alloy is the material of choice for the porous bone ingrowth materials for non-cemented total Joint arthroplasty. Recent studies have shown the importance of controlling the macro, micro, and nano surface topographies on the bone apposition surfaces of these implants. Historically, much attention has been given to the designs of macro fixation features (millimeter scale), and the design of micro fixation porosity (micrometer scale). More recently, the importance of the nano-surface texture (nanometer scale) is being recognised as an integral component of the design. Nano-textures are being enhanced during implant processes to optimise the bond between implant and bone. The ultra-hydrophilic nano-texture of an implant interacts with the corresponding nano-texture of the outer cell membranes to increase cell adhesion and differentiation. This speeds the osseointegration rate between Ti alloys, and the surrounding osteoblast tissues. Living cells sense and respond to surface texturing on the nanoscale which in turn direct stem cell and osteoblast differentiation. This has been recognised to improve the speed at which the implant interface bonds to bone with the end goal of ultimately allowing patients to weight bear on non-cemented arthroplasty implants sooner. One surface modification treatment technique of particular promise is nano-texturing via. electrochemical anodization to form arrays of vertically aligned, laterally spaced titanium dioxide (TiO2) nanotubes on titanium implant surfaces in areas where enhanced implant-to-bone fixation is desired. Bio-mimicking TiO2 nanotube arrays are superimposed onto existing porous surface micro-structures to further enhance the already known bone ingrowth properties of these porous structures. These nanotube arrays show an accelerated osseointegration. Foundational work has demonstrated that the TiO2 nanotube surface architecture significantly accelerates osteoblast cell growth, improves bone-forming functionality, and even directs mesenchymal stem cell fate. Current generation nano-surface modification technologies show improved osseointegration response between implant materials and surrounding tissue and also provide surfaces that resist microbial adhesion. Implant surfaces treated with and without TiO2 nanotubes were compared to grit blasted Ti controls in-vitro and in-vivo. The samples we evaluated after exposure to human mesenchymal stem cell (hMSC). Additionally, implants have been evaluated in multiple animal models with and without TiO2 nanotubes. The bones with implants were retrieved for mechanical testing and histology analysis. The average bond strength was significantly higher (150% to 600%, depending on the in-vivo animal model) for TiO2 nanotube implants compared to the non-treated Ti control implants. The histology confirms direct bonded growth of new bone onto the nanotubes with a significantly less trapped amorphous tissue at the implant-bone interface compared to the controls. Both in-vitro and in-vivo analysis indicates that TiO2 nano-texturing enhances the speed and proliferation of osseointegration. This surface treatment technique can be applied to non-porous or porous surfaces on TJA implants where improved bone fixation is desired

Osteoarthritis (OA) is a debilitating disease characterised by degradation of articular cartilage and subchondral bone remodeling. Current therapies for early or midstage disease do not regenerate articular cartilage, or fail to integrate the repair tissue with host tissue, and therefore there is great interest in developing biological approaches to cartilage repair. We have shown previously that platelet-rich plasma (PRP) can enhance cartilage tissue formation. PRP is obtained from a patient's own blood, and is an autologous source of many growth factors and other molecules which may aid in healing. This raised the question as to whether PRP could enhance cartilage integration. We hypothesise that PRP will enhance integration of bioengineered cartilage with native cartilage. Chondrocytes were isolated from bovine metacarpal-phalangeal joints, seeded on a porous bone substitute (calcium polyphosphate) and grown in the presence of FBS to form an in vitro model of osteochondral-like tissue. After 7 days, the biphasic constructs were soaked in PRP for 30 minutes prior to implantation into the core of a ring-shaped biphasic explant of native bovine cartilage and bone. Controls were not soaked in PRP. The resulting implant-explant construct was cultured in a stirring bioreactor in serum free conditions for 2 weeks. The integration zone was visualised histologically. A push-out test was performed to assess the strength of integration. Matrix accumulation at the zone of integration was assessed biochemically and the gene expression of the cells in this region was assessed by RT-PCR. Significance (p<0.05) was assessed by a student's t-test or one-way ANOVA with tukey's post hoc. PRP soaked bioengineered implants, integrated with the host tissue in 73% of samples, whereas control bioengineered implants only integrated in 19% of samples based on macroscopic evaluation (p<0.05). The integration strength, as determined by the normalised maximum force to failure, was significantly increased in the PRP soaked implant group compared to controls (219 +/− 35.4 kPa and 72.0 +/− 28.5 kPa, respectively, p<0.05). This correlated with an increase in glycosaminoglycan and collagen accumulation in the region of integration in the PRP treated implant group, compared to untreated controls after 2 weeks (p<0.05). Immunohistochemical studies revealed that the integration zone was rich in collagen type II and aggrecan. The cells at the zone of integration in the PRP soaked group had a 2.5 fold increase in aggrecan gene expression (p=0.05) and a 3.5 fold increase in matrix metalloproteinase 13 expression (p<0.05) compared to controls. PRP soaked bio-engineered cartilage implants showed improved integration with native cartilage compared to non-treated implants, perhaps due to the increased matrix accumulation and remodeling at the interface. Further evaluation is required to determine if PRP improves integration in vivo

Acetabular fractures, particularly in the geriatric population are on the rise. A recent study indicated a 2.4-fold increase in the incidence of acetabular fractures, with the fastest rising age group, those older than the age of 55. Controversy exists as to the role and indications for total hip arthroplasty (THA), particularly in the acute setting. Three common scenarios require further evaluation and will be addressed. 1.) What is the role of THA in the acute setting for young patients (< 55 years old)? 2.) What is the role and indications for THA in the older patient population (>55 years) and what are surgical tips to address these complex issues? 3.) What are the outcomes of THA in patients with prior acetabular fractures converted to THA?. Acetabular fractures in young patients are often the result of high energy trauma and are a life changing event. In general, preservation of the native hip joint and avoidance of arthroplasty as the first line treatment should be recommended. A recent long-term outcome study of 810 acetabular fractures treated with Open Reduction and Internal Fixation (ORIF) demonstrated 79% survivorship at 20 years with need for conversion to THA as the endpoint. Risk factors for failure were older age, degree of initial fracture displacement, incongruence of the acetabular roof and femoral head cartilage lesions. In selected younger patients, certain fracture types with concomitant injuries to articular surfaces may best be treated by acute THA. In the elderly patient population, acetabular fractures are more likely the result of low energy trauma but often times result in more displacement, comminution and damage to the articular surface. Osteoporosis and generalised poor bone quality make adequate reduction and fixation a challenge in these acute injuries. As such, the role of acute arthroplasty is becoming more widespread. Consideration should be given to delayed arthroplasty in certain patients to allow time for fracture healing followed by THA. However, early mobilization and weight bearing is important in the elderly population and consideration should be given to acute THA. The challenge remains gaining appropriate acetabular fixation in the fractured, osteoporotic bone. Early results showed high complication rates with acetabular fixation. However, newer fixation surfaces and advances in ORIF techniques have led to improved results. In addition, the need for complex acetabular reconstruction with the use of cages or cup cage constructs may be required in this setting. Appropriate 3-D imaging is essential to evaluate the extent of involvement of the anterior and posterior columns as well as the acetabular walls. Mears et al. reported on 57 patients who underwent THA for acute acetabular fracture and reported results at a mean of 8.1 years. 79% of patient reported good or excellent results and no acetabular cups were revised for loosening. One of the more common scenarios is the patient that presents with a prior ORIF of an acetabular fracture that has developed post-traumatic arthritis or avascular necrosis of the hip and requires conversion to THA. Challenges in this patient population include dealing with prior hardware that may interfere with THA component fixation, severe stiffness of the joint making exposure difficult and prior heterotopic ossification that may put neurovascular structures at risk. Previous studies have demonstrated lower long-term survivorship of the acetabular component (71% at 20 years) compared to primary THA for osteoarthritis. New acetabular fixation surfaces should mitigate the risk of aseptic loosening in this challenging patient population

Introduction. Distal femur fracture is a critical issue in orthopedic trauma, because it is difficult to manage especially in cases with intra-articular fracture. Osteoporosis may cause instability of implant and increase complications. Few studies investigate on the stability of distal femur osteoporotic fracture and the behaviors under cycling. Our hypothesis was that the stiffness of construct would decrease as cycling in osteoporotic bone. Materials and Methods. Seven cadaver specimens were used in this study. Relative bone density for each specimen was evaluated using CT scanning by three known calibration phantoms scanned simultaneously with the specimen. All cadaver specimens were divided normal (group 1) and osteoporosis (group 2) in accordance with the bone density. The titanium distal femur locking plates with 6 screws placed in distal femur condyle and 4 in shaft. A 10 mm gap with 65 mm proximal to the center of articular surface and a vertical fractural line between intra-articular were created to simulate AO C2 type fracture. Each specimen was cyclically loaded in two-phase at a frequency of 2 Hz. Phase 1 was set at 1000 N for 10000 cycles. In phase 2, the load was set at 2000 N for 10000 cycles. Then, the specimen was loaded up to failure at a rate of 5 mm/min. Stiffness was evaluated from the linear portion of load-displacement curve at 2000 cycle interval. Results and Discussion. Figure 1 showed the stiffness deterioration during cycling. Group 1 expresses the cadaveric specimen with normal bone density, and group 2 expresses osteoporosis. The stiffness of group 1 (with normal bone density) decreased for 26.2 % after 20000 cycles, however, group 2 (osteoporotic bone) revealed 90.3 % decay in stiffness. The stiffness decay observably when the load increased from 0 to 1000 N and from 1000 to 2000 N. The maximum load for group1 and group 2 were 4883±134 N and 2538 N, respectively. It can be found the normal bone density group showed intact circular hole, however, the osteoporotic bone revealed an oval contour. The subsidence of screws increased the risk of screw loosening and instability. It can be concluded that the bone quality and cyclic loading could be the important factors that affect the stability and failure strength of the construct

Introduction. Various implant designs and bearing surfaces are used in TKR. The use of All Poly Tibia and poly moulded on Tibial metal base plate has been in practice since long. Recently due to the reports on wear and osteolysis in modular articulations, these components have generated significant interest. Aim. To report early medium term results in elderly (>70 years) patients. Method. Study of 130 cases done between 2005–2009. All cases were performed by the author. Inclusion Criteria:. Patients with physiological age > 70 years. Patients with low functional demand. Good bone quality. Exclusion Criteria: Inflammatory arthropathy. Osteoporosis and poor bone quality. High functional demand. All Poly Tibial component/ Moulded Metal back Tibia implantations were performed. A PS design was used in all cases fixed with CMW 1 gentamicin cement. Results. 12 cases were lost to follow up. 11 patients deceased due to medical conditions. This left us with 107 cases at the time of the last follow up. Mean age at index surgery was 72.5 years.(70–91 years). Preop KSS average was 42 (25–62). Post operative at the latest Follow up was 89 (68–97). Of 107 cases there were 4 revisions - two for deep sepsis and two for periprosthetic fractures. There were no revisions for aseptic loosening or osteolysis. All 103 cases are performing well functionally and clinically. 19 cases have a nonprogressive radiolucent line beneath the Tibial component. Discussion. Use of Monobloc Tibia is somewhat controversial. The first Total condylar Knee was an all poly design in early 70s. 1. The monobloc tibia eliminates backside wear. The overall thickness of polyethylene in this implant is 2 to 4mm thicker in allpoly tibia design. The metal base plate with compression moulded polyethylene dissipates stresses evenly in osteopaenic bones. The polywear and osteolysis are two most important factors for aseptic loosening. If Symptomatic, loosening warrants a revision surgery. Metal back fixed bearing implant has a disadvantage that it wears from both the surfaces. The highly polished trays are supposed to reduce the wear but it is too early for a statistically significant conclusion. Functionally low demand patients have lesser stresses as compared to their counterparts. The surgical technique for insertion of these implants is slightly demanding as compared to modular implants. The combination of perfect alignment and soft tissue balance creates an environment for a successful TKR. The choice of Monobloc Tibial component for functionally low demand age group patients reduce the chances of premature wear and osteolysis. In elderly patients the implant should outlive the patient. Here it is observed that at early medium term (5 to 9 yr.s) aseptic loosening and subsequent revision chances are low. The Monobloc Tibial component is cheaper as compared to its metal back counterpart. Conclusion. An excellent clinical result in our hands for this group of patients supports the continued use of this implant strongly

Introduction. Glenoid loosening, still a main complication in shoulder arthroplasty, could be related to glenohumeral orientation and conformity, cementing techniques, fixation design and periprosthetic bone quality [1,2]. While past numerical analyses were conducted to understand the relative role of these factors, so far none used realistic representations of bone microstructure, which has an impact on structural bone properties [3]. This study aims at using refined microFE models including accurate cortical bone geometry and internal porosity, to evaluate the effects of fixation design, glenohumeral conformity, and bone quality on internal bone tissue and cement stresses under physiological and pathological loads. Methods. Four cadaveric scapulae were scanned at 82µm resolution with a high resolution peripheral quantitative computer tomography (XtremeCT Scanco). Images were processed and virtually implantated with two anatomical glenoid replacements (UHMWPE Keeled and Pegged designs, Exactech). These images were converted to microFE models consisting of nearly 43 million elements, with detailed geometries of compact and trabecular bone, implant, and a thin layer of penetrating cement through the porous bone. Bone tissue, implant and cement layer were assigned material properties based on literature. These models were loaded with a central load at the glenohumeral surface, with the opposite bone surface fully constrained. Effects of glenohumeral conformity were simulated with increases of the applied load area from 5mm-radius to a fully conformed case with the entire glenoid surface loaded. The models were additionally subjected to a superiorly shifted load mimicking torn rotator cuff conditions. These models were solved and compared for internal stresses within the structures (Figure 1) with a parallel solver (parFE, ETH Zurich) on a computation cluster, and peak stresses in each region compared by design and related to apparent bone density. Results. Peak cement stresses were generally located at the interface with bone rather than implant (p<0.05), and peak bone stresses occurred around the cemented region. A larger trabecular load share was predicted with the Pegged compared to the Keeled design (Figure 2a). Superior load shift reduced this ratio but resulted in slight stress increase in the cement and implant, with the Keeled design less sensitive to this shift (Figure 2b). These effects were more pronounced with decreased overall bone density (Figure 2c). Increasing conformity significantly affected peak stresses in the cement and implant for both Keeled and Pegged designs (Figure 3) (p<0.041), but only significantly changed bone stresses for the Keeled design (p<0.047). Generally higher peak cement and trabecular bone stresses were predicted for the Pegged design. Discussion. Our detailed microFE analyses suggest that implant fixation design affects the sensitivity of internal stresses to glenohumeral load shifts, in particular within the cement region and through alterations in load sharing in the periprosthetic bone. Future steps including reverse replacements and more physiological loading conditions, combined with experimental validation tests in dynamic loading, will provide improved insights into the clinical incidences of glenoid loosening

Introduction. Titanium (Ti) alloys are used as porous bone ingrowth materials on non-cemented knee arthroplasty tibial tray implants. Nano-surface mechanism that increase the osseointegration rate between Ti alloys, and surrounding tissue has been recognized to improve the interface to ultimately allow patients to weight bear on non-cemented arthroplasty implants sooner. Bioactive TiO. 2. nanotube arrays has been shown to accelerate osseointegration. Ideally, these surfaces would both increase the adhesion of bone to the implant and help to reduction of infection to substitute for antibiotic bone cement. This study examines a combination treatment of both TiO. 2. nanotubes combined with silver nano-deposition, that simultaneously enhances osseointegration while improving infection resistance, by testing ex vivo implantation stability in an equine cadaver bone followed by in vitro and in vivo analysis to understand the biocompatibility and early stage osseointegration. Methods. 100nm diameter and 300nm length TiO. 2. nanotubes were formed on a CP titanium surface using anodization method at 20V for 45mins using 1% HF electrolyte. Silver deposition on TiO. 2. nanotubes were performed using 0.1M AgNO. 3. solution at 3V for 45s. Figure 1 shows SEM images showing (a) TiO. 2. nanotubes of 300nm length and (b) nanotubes with silver coating). Ti anodized samples with and without silver nanotubes implanted into an equine cadaver bone in an ex vivo manner to study the stability of nanotubes and the adherence of silver deposition. Silver release study was performed for a period of 14 days in a similar ex vivo manner. Dimensions for implantation samples: 2.5 mm diam. × 15 mm. For cell culture, circular disc samples 12.5mm in diameter and 3 mm in thickness were used to study the bone cell-material interactions using human fetal osteoblast (hFOB) cells. To evaluate the cell proliferation, MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide) assay was used. The in vitro cell-materials interaction study was performed for a period of 4 and 7 days. In vivo study was performed using rat distal femur model for a period of 12 weeks with dense Ti samples as control (Sample dimensions: 3mm diam. × 5mm). At the end of 12 weeks, the samples were analyzed for early stage osseointegration using histological analysis and SEM imaging. Results. No significant changes in the morphology of nanotubes was observed due to the implantation process which signifies the damage resistance these nanotubes can endure during implantation and explantation. Figure 2 shows SEM images of (a) & (b) nanotubes without silver coating before and after implantation and (c) & (d) nanotubes with silver coating before and after implantation respectively. Silver nanocoatings can be observed after implantation which shows the adherence of the antimicrobial nano-coating on the surface of nanotubes. Cumulative release profiles of silver ions after 14 days showed the total release was in the effective range for antimicrobial characteristics and was well below the toxic limit specified for human cells (10 ppm) Figure 3(a) shows cumulative release profile of silver after 14 days. MTT assay and SEM images show good cell proliferation, antimicrobial effect, and increase in cell density after 7 days for samples with nanotubes and silver with no cytotoxic effects and good cell attachment on the samples as shown in Figure 3(b) MTT assay results showing cell densities after 4 and 7 days and Figure 3(c) SEM images showing cell attachment after 4 and 7 days on samples. Histological analysis and SEM images showed osteoid formation around the implant with improved bonding towards the implant and bone showing signs of early stage osseointegration. Figure 4 shows histological and SEM images showing bonding between bone and implant surface for respective samples after 12 weeks. Conclusions. Mechanically stableTiO. 2. nanotubes with strongly adhered antimicrobial silver coating were grown on the surface of titanium which were biocompatible and non-toxic. In vitro and in vivo tests indicate improved cell-materials interaction with signs of early stage osseointegration. This nano-surface treatment shows promise towards simultaneously improving early stage osseointegration and providing an infection barrier on bone ingrowth materials